Aberrant
fatty acid (FA) metabolism is a hallmark of proliferating cells, including untransformed fibroblasts or
cancer cells. Lipolysis of intracellular
triglyceride (TG) stores by adipose
triglyceride lipase (ATGL) provides an important source of FAs serving as energy substrates, signaling molecules, and precursors for
membrane lipids. To investigate if ATGL-mediated lipolysis impacts cell proliferation, we modified ATGL activity in murine embryonic fibroblasts (MEFs) and in five different
cancer cell lines to determine the consequences on cell growth and metabolism. Genetic or pharmacological inhibition of ATGL in MEFs causes impaired FA oxidation, decreased ROS production, and a substrate switch from FA to
glucose leading to decreased AMPK-mTOR signaling and higher cell proliferation rates. ATGL expression in these
cancer cells is low when compared to MEFs. Additional ATGL knockdown in
cancer cells did not significantly affect cellular lipid metabolism or cell proliferation whereas the ectopic overexpression of ATGL increased lipolysis and reduced proliferation. In contrast to ATGL silencing, pharmacological inhibition of ATGL by Atglistatin© impeded the proliferation of diverse
cancer cell lines, which points at an ATGL-independent effect. Our data indicate a crucial role of ATGL-mediated lipolysis in the regulation of cell proliferation. The observed low ATGL activity in
cancer cells may represent an evolutionary selection process and mechanism to sustain high cell proliferation rates. As the increasing ATGL activity decelerates proliferation of five different
cancer cell lines this may represent a novel therapeutic strategy to counteract uncontrolled cell growth.